Come up with a name for your new list and we'll add to it:
EnteroMedics raised a round of funding on , . Investors include
Charter Life Sciences.
EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…